CXCR2 antagonist 4

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

CXCR2 antagonist 4 

CXCR2 antagonist 4 (compound 7) 是一种有效的 CXCR2 拮抗剂，IC50 为 0.13 μM。CXCR2 antagonist 4 可抑制 CXCL8 诱导的胞质钙离子增加 (IC50 = 27 μM)。CXCR2 antagonist 4 可用于抗癌研究。

CXCR2 antagonist 4

CXCR2 antagonist 4 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

CXCR2 antagonist 4 (compound 7) is a potent CXCR2 antagonist with an IC50 value of 0.13 μM. CXCR2 antagonist 4 can inhibit CXCL8-induced cytosolic calcium increase (IC50 = 27 μM). CXCR2 antagonist 4 can be used for researching anticancer[1].

IC50 & Target[1]

CXCR2

0.13 μM (IC50)

分子量

368.42

Formula

C15H14F2N4OS2
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Van Hoof M, et al. Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[4,5-d]pyrimidine. Eur J Med Chem. 2022;235:114268.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务